Natural experiments in Wales, Australia, and Canada — where eligibility switched based on birth date — consistently showed lower dementia rates among shingles vaccine recipients. The newer Shingrix vaccine appears more protective than the older Zostavax. The leading hypothesis is an immunomodulatory effect that may also suppress other neurotropic herpesviruses.